Key words: myoblast differentiation/monoclonal antibody/myoblast fusion with HVJ (Sendai virus)/artificial myotube /kinase activity of src gene product ABSTRACT. Quail myoblasts transformed with a temperature-sensitive mutant of Rous sarcoma virus (ts-RSV) proliferate and do not differentiate at 35.5°C, the permissive temperature for the virus, whereas their myoblast differentiation proceeds at 41.0°C, a non-permissive temperature. In this experimental system, myogenic differentiation is controlled by src gene products. Using QM-RSV cells as an antigen, a monoclonal antibody, Mb-N3, was prepared. Expression of Mb-N3 antigen was found to increase during differentiation. Therefore, in studies on the mechanism of myogenic differentiation, we examined the expression of Mb-N3 antigen on spontaneously forming myotubes formed at 41.0°C and fused myoblasts with hemagglutinating virus of Japan (HVJ, Sendai virus) disregarding programmed processes for myogenic differentiation. When the myoblasts cultured at 35.5°C were treated with HVJ, they fused with each other. These fused myoblasts were elongated and were morphologically similar to spontaneously forming myotubes. Thus, we called fused myoblasts with HVJ "artificial myotubes. " During culture at 35.5°C, the artificial myotubes did not show increased expression of Mb-N3 antigen and increase of creatine kinase activity, which are markers of normal biochemical differentiation. When artificial myotubes were cultured at 41.0°C, expression of Mb-N3 antigen and creatine kinase activity increased. These results suggest that the expression of the antigen is regulated by kinase activity derived from src gene products even after compulsory cell fusion. Moreover, compulsory fusion does not cause myogenic differentiation and expression of Mb-N3 antigen. Thus it seems that the differentiation program must proceed in order for myogenic differentiation and expression of Mb-N3 antigen to take place.
In myogenesis, myoblasts that have been proliferating continuously stop replicating and pass through the series of steps of cell recognition, cell interaction, cell adhesion and cell arrangement (15, 33) . Simultaneously, the myoblasts fuse to form myotubes. During these morphological changes, the cells begin to express muscle-specific proteins, and the myotubes differentiate into muscle fibers. As these very remarkable phenomena can be reproduced in vitro, studies on myogenic differentiation are very useful for analyzing the mechanism of differentiation of higher animal cells. We have studied the mechanism of myoblast differentiation, especially myoblast fusion, using quail myoblasts transformed with a temperature-sensitive mutant of Rous sarcoma virus (ts-RSV), QM-RSV cells (13, 14) , because with these cells, myogenic differentiation can be controlled by change of the culture temperature. When QM-RSV cells are cultured at 41.0°C, they become fusion-competent within 12 hr and the appearance of myotubes starts after about 18 hr and reaches a plateau within 48 hr (13, 14) . This control is caused by change in tyrosine kinase activity of the src gene products of ts-RSV (13). The control of differentiation by src gene products is relaxed and cells differentiate into myotubes at 41.0°C; however, at 35.5°C, which is apermissive temperature for the virus, differentiation is inhibited (4, 8, 13, 22) .
As myoblast differentiation involves a series of steps, as described above, the expression of various genes is thought to increase or decrease in order during the differentiation process. During myogenic differentiation, manymorphological and biochemical changes are observedincells (1, 2, 7, 9, 21, 25, 26, 32, 34, 35) . Some characteristic monoclonal and polyclonal antibodies for antigens that are associated with myogenesis have been prepared and used in studies on myogenic differentiation (3, 5, 6, 10, ll, 17, 18, 19, 23, 28 Therefore, in this work we first tried to produce monoclonal antibodies associated with myogenic differentiation. We obtained a monoclonal antibody, named Mb-N3, whose antigen was expressed more strongly on myotubes than myoblasts.
To obtain information of the relation between the order of differentiation events and myogenic differentiation, we prepared artificial multinucleated cells with hemagglutinating virus of Japan (HVJ, Sendai virus) and compared the expressions of Mb-N3 antigen as a marker of differentiation on spontaneous myotubes and artificial multinucleated cells.
MATERIALSANDMETHODS
Cell culture. Quail myoblasts transformed using a temperature-sensitive mutant of Rous sarcoma virus (ts-RSV),
QM-RSV cells, were prepared as described previously (13). Dulbecco's modified Eagle's medium (DMEM) plus 2 mM glutamine (Nissui Pharmaceutical Co. , Tokyo, Japan), penicillin (100 U/ml) and streptomycin (0.1 mg/ml) was used as culture medium. This medium was supplemented with fetal bovine serum (FBS) at 20% for use as growth medium and at 5% for use as differentiation medium. Differentiation was initiated by replacing the growth medium by differentiation medium and shifting the culture temperature from 35.5°C to 41.0°C. After these changes, myoblast fusion occurred within 24 hr. Primary cultures of quail and chick myoblasts, and quail fibroblasts were prepared and cultured as described previously (13). QM-RSV cells, primary QM cells and primary chick myoblasts were cultured in plastic dishes coated with collagen (Cell matrix, Type I-P, Nitta Gelatin, Yao City, Osaka, Japan). Glass dishes were used for fibroblasts.
The mouse skeletal muscle cell line C2C12 formed myotubes in the differentiation medium consisting of DMEM containing 5% horse serum, whereas for growth of these cells, DMEM containing 10% FBS was used. BC3H1 cells, which have been used as a model of smooth muscle, were cultured in DMEM containing 10% FBS. C2C12 cells and BC3H1 cells were cultured in gelatincoated plastic dishes. Quail heart cells were prepared from 6-day-old quail embryos. These cells were cultured in DMEM containing 10% calf serum (CS fjtg/m\ antipain) for 1 hr at room temperature. Pectoral muscles were prepared from 4-13-day-old quail embryos. The preparations were centrifuged (320,000 x g) at 4°C for 10 min, and the supernatants were mixed with sample buffer (62.5 mM Tris, 10% glycerol, 2.3% SDS, 0.005% bromphenol blue), and subjected to 12.5% SDS-PAGE by the method of Laemmli (16). Equal amounts of protein, measured by the method of Lowry et al. (20), were applied. The sample solution was neither treated with a reductant nor boiled, thus the antigen was not reduced. The proteins were transferred electrophoretically onto nitrocellulose membranes (Bio-Rad Laboratories, CA) in transfer buffer (0.1 M Tris, 0.192 M glycine), which did not contain methanol. After Western blotting, blocking was carried out with 5% skim milk in Tris-buffered saline (TBS; 20mM Tris, 500mM NaCl, pH7.5) for 1 hr at room temperature, and then the nitrocellulose membranes were incubated overnight with Mb-N3 at room temperature. Horseradish peroxidase-conjugated goat anti-mouse IgG (Bio-Rad Laboratories, CA) was used as the second antibody. The buffer used for washing the membranes was TBS containing 0.5% Tween-20 (TTBS). The first and second antibodies were diluted with TTBS containing 3% skim milk.
Fusion ofmyoblasts with HVJ(Sendai virus)
. HVJ for fusion was propagated in chick embryos, concentrated by ultracentrifugation as described previously (12) and inactivated with UVlight. QM-RSV cells were cultured at 35.5°C for 24 hr in growth medium seeded at 5.9x 105 cells per collagencoated dish (60mm diameter), washed once with PBS (-) and treated with 400 (A of inactivated HVJ solution (500 HAu /ml) per dish. They were then left to stand on ice for 30 min, washed once with PBS (-), and cultured in 3ml of fresh differentiation medium at 35.5°C. "Artificial myotubes" appeared within 12 hr in these cultures.
RESULTS
Preparation of monoclonal antibodies. We have tried to obtain monoclonal antibodies that are useful for investigating myoblast differentiation and prepared about 250 antibodies. These antibodies can be classified as those expressed 1) mainly on myotubes, 2) mainly on myoblasts, and 3) on both myotubes and myoblasts and 4) antibodies inhibiting myoblast fusion. It has, however, been difficult to obtain antibodies of group 4). In the present study, we used Mb-N3 which was classified under group 1). To examine the expression of Mb-N3 antigen, QM-RSV cells cultured at 35.5°C ( Fig. la, with myogenic differentiation, we next examined the expression of the antigen in 4-13-day-old quail embryos. Extracts prepared from individual embryonic muscles were subjected to immunoblotting.
As shown in Fig. 2 , expression of the antigen increased during development to a maximumin 12-day-old embryos (lane 9 in Fig. 2) , and then began to decrease. These results strongly suggest that the Mb-N3 antigen is associated with myogenic differentiation. Relationship of expression ofMb-N3 antigen with kinase activity.
As described above, Mb-N3 antigen was highly expressed on QM-RSV cells at 41.0°C, a non-permissive temperature.
Wenext examined the time course of its expression on QM-RSV cells after increasing the culture temperature. QM-RSV cells were cultured at 41.0°C after preculture at 35.5°C, and cell lysates were prepared at different intervals. These cell lysates were then subjected to immunoblotting and the quantity of the antigen expressed wasmeasured by densitometry (Fig. 3) . After increasing the temperature to 41.0°C, expression of the antigen was not detectable for the initial 6 hr, but a rapid increase was detected between 6 to 12 hr. This result suggests that expression of the Mb-N3 antigen increases rapidly during the 6-12 hr period after the increase in temperature. As reported previously, incubation for 10-12hr at 41.0°C is required for QM-RSV cells to become fusion-competent (14). Next, expression of Mb-N3 antigen on QM-RSV cells cultured for 10 hr at 41.0°C was examined by indirect immunofluorescence staining to clarify its relationship with fusioncompetence. Most of the cells cultured at 41.0°C for 10 hr stained intensely with Mb-N3 (Fig. 4) . From these observations, it seems that expression of the Mb-N3 antigen is associated with acquisition of fusion-competence.
Mb-N3 antigen was expressed intensely on the myotubes 24 hr after the increase in temperature to 41.0°C when the myotubes were formed as well as the cells with fusion-competence. However, at this time, unlike after culture for 10 hr, remaining unfused mononucleated cells were scarcely stained with Mb-N3 (see Fig. Id) . These results suggest that this antigen disappears from cells that remain un fused. The staining pattern of myoblasts culturedat 41.0°C for 10 hr and that ofmyotubes after 24 hr were also somewhat different: that of myoblasts after 10 hr being diffuse and that of myotubes after 24 hr appearing as nondiffuse staining with some aggregates (Fig. Id) . Thus the expression and distribution of Mb-N3 antigen seem to change dynamically with the incubation time during differentiation at 41.0°C. T he finding that expression of Mb-N3 antigen on QM-RSV cells increased at 41.0°C but was suppressed at 35.5°C suggests that expression of Mb-N3 antigen is regulated by the tyrosine kinase activity of src gene pro- Fig. 7) . At 35.5°C, the antigen was hardly expressed, as observed from immunofluorescence staining (lanes 1 and 2 in Fig. 7) . The antigen was not detectable under reduced conditions. We also investigated whether the Mb-N3 antigen had a sugar chain. For this, QM-RSV cells were treated with tunicamycin, which blocks protein glycosylation and expression of glycoprotein, and then lysates of the cells were subjected to immunoblotting with Mb-N3. A clear band was detected with Mb-N3 (lane 4 in Fig. 7 ), but the molecular weight of this material was less than that of the antigen of control cells. This result suggests that Mb-N3 antigen has a sugar chain, but the recognition site of Mb-N3 is in its protein moiety. ting. At 41.0°C, Mb-N3 antigen was expressed in the same degree of intensity in both the Ca2+-deficient medium (lane 5 in Fig. 8 ) and the normal differentiation medium (lane 3 in Fig. 8 Characteristics of artificial myotubes induced by HVJ. As described above, biochemical differentiation could be distinguished from myoblast fusion under certain experimental conditions. However, myoblast fusion and biochemical differentiation usually proceed simultaneously, and there seems to be a close correla- tion between the two events. Furthermore, differential events are thought to proceed in a programmed order. To clarify the relationship between myogenic differentiation and this programmed order, we prepared multinucleated fused cells by fusion using HVJ under conditions that disregard programmed processes for differentiation. QM-RSV cells cultured at 35.5°C were treated with HVJ and cultured at 35.5°C, not 41.0°C, to prevent spontaneous myoblast fusion. Fused multinucleated cells began to appear after about 12 hr treatment with the virus (Fig. 9a) and were formed appreciably after 48 hr (Fig. 9b) Wenext investigated whether biochemical differentiation proceeded in artificial myotubes prepared in this way by measuring CK activity as a marker of biochemical differentiation (Fig. 10) . QM-RSV cells were cultured at 35.5°C for 24hr, then fused by addition of HVJ. After another 24 hr, the cells were cultured further at 41.0°C in Ca2+-deficient medium to prevent spontaneous myoblast fusion at 41.0°C.
Lysates of QM-RSV cells were prepared at various times. Artificial multinucleated cells had a tubelike shape but showed no increase of CK activity on culture at 35.5°C. On the other hand, when the multinucleated cells were cultured at 41.0°C, their CK activity increased with the incubation time. These results suggest that myoblast fusion alone is not sufficient to increase CK activity, but that CK activity is regulated with kinase derived from src g ene products.
We also examined the extent of expression of desmin on spontaneous myotubes and artificial myotubes. Since desmin is a muscle-specific protein, it has often been used as a marker of biochemical differentiation of muscle. As expected, desmin was detectable on spontaneous myotubes at 41.0°C. On artificial myotubes, however, it was not expressed at 35.5°C in spite of myoblast fusion. These results suggest that formation of artificial myotubes from presumptive myoblasts does not cause biochemical differentiation. Expression of Mb-N3 antigen on artificial myotubes. To investigate the relation between expression of surface antigen and the fusion, we examined the expression of Mb-N3 antigen as a marker of differentiation on artificial myotubes. After treatment with HVJ, QM-RSV cells were cultured at 35.5°C for 24hr and then their immunofluorescence staining was examined. Expression of Mb-N3 antigen on artificial myotubes was as weak at 35.5°C as that on myoblasts cultured normally at 35.5°C, as shown in Fig. lb (Fig. lla and  b) .
When these artificial myotubes were cultured at 41.0°C for 24 hr, their expression of Mb-N3 antigen became as intense as that of spontaneous myotubes shown in Fig. Id. (Fig. lie and d) . This experiment was performed under low Ca2+ conditions to prevent spontaneous myotube formation at 41.0°C, thus, the myotubes observed were induced by HVJ treatment. These results suggest that expression of the Mb-N3 antigen gene is controlled by the kinase activity of sre gene products even after formation of artificial myotubes, and also suggest that myoblast fusion alone is not enough to induce expression of Mb-N3 antigen.
DISCUSSION
We have tried to prepare monoclonal antibodies against components associated with myogenic differentiation to analyze the mechanism of myotube formation. As described in this paper, a monoclonal antibody named Mb-N3 was isolated using QM-RSV cells as an antigen. Expression of its antigen increased during myogenic differentiation both in vivo and in vitro, although this antibody did not block either fusion or biochemical differentiation. Therefore, Mb-N3 appears to be useful for investigating the dynamic state of the antigen that is associated with myogenic differentiation. During differentiation, the antigen was found to be strongly expressed by myoblasts immediately before myoblasts became fusion-competent. This finding suggests that the molecule recognized by Mb-N3 is associated with the event of becoming fusion-competent. We think that Mb-N3 recognizes a molecule in a non-active epitope that is associated with myogenic differentiation. On the other hand, after culture at 41.0°C for 24hr, when the cells had differentiated sufficiently to form myotubes, Mb-N3 antigen was expressed strongly and specifically on the surface of myotubes. Expression of Mb-N3 antigen starts before the fusion-competent step, and persists in the myotubes, but disappears from remaining mononucleated cells that do not form myotubes. These findings suggest that the Mb-N3 gene associated with differentiation is expressed transiently at an essential step and then is suppressed.
However, its expression on the myotubes may be necessary to maintain the myotubes functionally and/or morphologically. A little expression of Mb-N3 antigen at 35.5°C suggests that the expression of Mb-N3 antigen is necessary for myblasts intrinsically. It also seems that the increase of the expression of this antigen is necessary for myogenic differentiation. Mb-N3 antigen seems to be associated with several events in myogenic differentiation.
Recently, we found that the expression of Mb-N3 antigen was completely blocked by treatment with doxorubicin, which is an inh ibitor of myoblast fusion (unpublished data). As described above, myoblast fusion and biochemical differentiation can be distinguished under certain experimental conditions. However, in general, the two events proceed simultaneously and are closely correlated. To investigate the correlation between myoblast fusion and biochemical differentiation and the necessity of the programmed differentiation process, the expression of Mb-N3 antigen on artificial myotubes formed by fusion of undifferentiated myoblasts was examined, excluding the differentiation program. Mb-N3 antigen was not expressed on the artificial myotubes at 35.5°C, but was strongly expressed when the artificial myotubes were cultured at 41.0°C. It seems that expression of the Mb-N3 antigen on these artificial myotubes is still controlled by the kinase activity of src gene products. Expression of Mb-N3 antigen, biochemical differentiation and cell fusion were inhibited at 35.5°C, in spite ofmyotube formation, when myoblasts were fused with HVJ. These results suggest that orderly progress of the differentiation program, as well as myoblast fusion, is necessary for myogenic differentiation. Furthermore, it seems that phosphorylation of some protein(s) by kinase at 35.5°C is more closely concerned with earlier events than the events that control the expression of Mb-N3 antigen, biochemical differentiation and cell fusion. Now, weare purifying the Mb-N3 antigen by affinity chromatography to prepare the polyclonal antibody of the antigen for further examination of the correlation of the antigen with myogenic differentiation. We are also investigating the Mb-N3 antigen at a molecular level.
